NCT07828730Not yet recruiting
Sparrow App Guided Evaluation (SAGE) Vanguard Trial for Aortic Stenosis in Adults Aged Seventy and Older
Source: ClinicalTrials.gov · Last updated 18 Sept 2026
Brief summary (registry, in English)
The purpose of this research is to look at an approved intervention (Stethophone application) to obtain additional information about improving detection of moderate or severe aortic stenosis when compared with usual standard of care.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 1000 (estimated)
- First submitted
- 19 Aug 2026
- Start date
- Sept 2026
- Primary completion date
- Dec 2027
- Lead sponsor
- Sunnybrook Health Sciences Centre
- NCT number
- NCT07828730
What you commit to
- Study type: Interventional
- Planned participants: 1000
- From Sept 2026 to the primary completion date, Dec 2027
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Prior surgical or transcatheter aortic valve replacement.
Other illness
- Any condition that, in the opinion of the investigator or treating clinician, would preclude informed consent or make participation impractical or unsafe.
Other
- Known moderate or severe aortic stenosis before enrolment.
Who the study is looking for
- Age 70 years or older at the time of consent.
- Written informed consent from participant
- Receiving care at a participating primary care practice during the study period.
Age in the registry: 70 years to - · Sex: All · Accepts healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.